Trial Profile
DS-7113b injection phase II/III study An open label and extension study of DS-7113 injection in patients with cancer pain (subcutaneous injection)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 27 Jun 2016 Status changed from recruiting to completed.
- 09 Jun 2016 New trial record